Geron (GERN) EPS (Weighted Average and Diluted) (2016 - 2025)

Geron's EPS (Weighted Average and Diluted) history spans 9 years, with the latest figure at -$0.05 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 25.0% year-over-year to -$0.05; the TTM value through Dec 2025 reached -$0.13, up 51.85%, while the annual FY2025 figure was -$0.13, 51.85% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.05 at Geron, down from -$0.03 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.02 in Q2 2025 and bottomed at -$0.11 in Q4 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.08 (2023), against an average of -$0.07.
  • The largest annual shift saw EPS (Weighted Average and Diluted) decreased 28.57% in 2023 before it skyrocketed 80.0% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.09 in 2021, then dropped by 22.22% to -$0.11 in 2022, then increased by 27.27% to -$0.08 in 2023, then soared by 50.0% to -$0.04 in 2024, then fell by 25.0% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for GERN's EPS (Weighted Average and Diluted) are -$0.05 (Q4 2025), -$0.03 (Q3 2025), and -$0.02 (Q2 2025).